- Home
- DDL vs AURA Comparison
DDL vs AURA Comparison
Compare DDL & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDL
- AURA
- Stock Information
- Founded
- DDL 2014
- AURA 2007
- Country
- DDL China
- AURA United States
- Employees
- DDL N/A
- AURA N/A
- Industry
- DDL Catalog/Specialty Distribution
- AURA Biotechnology: Pharmaceutical Preparations
- Sector
- DDL Consumer Discretionary
- AURA Health Care
- Exchange
- DDL Nasdaq
- AURA Nasdaq
- Market Cap
- DDL 446.5M
- AURA 396.8M
- IPO Year
- DDL 2021
- AURA 2021
- Fundamental
- Price
- DDL $2.20
- AURA $6.18
- Analyst Decision
- DDL
- AURA Strong Buy
- Analyst Count
- DDL 0
- AURA 7
- Target Price
- DDL N/A
- AURA $22.29
- AVG Volume (30 Days)
- DDL 677.3K
- AURA 156.6K
- Earning Date
- DDL 11-05-2025
- AURA 11-11-2025
- Dividend Yield
- DDL N/A
- AURA N/A
- EPS Growth
- DDL 372.99
- AURA N/A
- EPS
- DDL 0.21
- AURA N/A
- Revenue
- DDL $3,335,962,059.00
- AURA N/A
- Revenue This Year
- DDL $8.90
- AURA N/A
- Revenue Next Year
- DDL $11.39
- AURA N/A
- P/E Ratio
- DDL $10.63
- AURA N/A
- Revenue Growth
- DDL 15.14
- AURA N/A
- 52 Week Low
- DDL $1.95
- AURA $4.35
- 52 Week High
- DDL $4.79
- AURA $12.38
- Technical
- Relative Strength Index (RSI)
- DDL 51.20
- AURA 40.01
- Support Level
- DDL $2.13
- AURA $6.20
- Resistance Level
- DDL $2.28
- AURA $6.61
- Average True Range (ATR)
- DDL 0.09
- AURA 0.28
- MACD
- DDL 0.01
- AURA -0.00
- Stochastic Oscillator
- DDL 60.00
- AURA 1.59
About DDL Dingdong (Cayman) Limited (each two representing three)
Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.